甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603087 甘李药业

已收盘 05-17 15:00:00

{"stockData":{"symbol":"603087","market":"SH","secType":"STK","nameCN":"甘李药业","latestPrice":48.65,"timestamp":1715929200000,"preClose":48.45,"halted":0,"volume":6537218,"delay":0,"floatShares":532000000,"shares":594000000,"eps":0.6511,"marketStatus":"已收盘","marketStatusCode":5,"change":0.2,"latestTime":"05-17 15:00:00","open":48.37,"high":49.13,"low":47.94,"amount":317000000,"amplitude":0.0246,"askPrice":48.65,"askSize":522,"bidPrice":48.64,"bidSize":24,"shortable":0,"etf":0,"ttmEps":0.6511,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":48.45,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":53.3,"lowLimit":43.61,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":594161750,"pbRate":2.67,"roa":"--","roe":"0.89%","epsLYR":0.6,"committee":-0.296943,"marketValue":28906000000,"floatMarketCap":25895000000,"peRate":74.719707,"changeRate":0.0041,"turnoverRate":0.0123,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-20。"},"requestUrl":"/m/hq/s/603087/wiki","defaultTab":"wiki","newsList":[{"id":"2436918835","title":"甘李药业：尹磊辞去公司董事职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2436918835","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2436918835?lang=zh_cn&edition=full","pubTime":"2024-05-17 19:08","pubTimestamp":1715944114,"startTime":"0","endTime":"0","summary":"甘李药业（SH 603087，收盘价：48.65元）5月17日晚间发布公告称，2024年5月17日，甘李药业股份有限公司董事会收到董事尹磊先生递交的《辞职报告》，尹磊先生因个人原因申请辞去公司董事职务，辞职后仍将在公司担任其他职务。2023年1至12月份，甘李药业的营业收入构成为：医药制造业占比100.0%。截至发稿，甘李药业市值为289亿元。文章来源：每日经济新闻原标题：甘李药业：尹磊辞去公司董事职务","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171919238b125ebb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171919238b125ebb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436992714","title":"甘李药业最新公告：董事尹磊辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2436992714","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436992714?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:50","pubTimestamp":1715943031,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司董事会收到董事尹磊递交的《辞职报告》，尹磊因个人原因申请辞去公司董事职务，辞职后仍将在公司担任其他职务。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700038926.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2436399255","title":"甘李药业：董事尹磊先生辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2436399255","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2436399255?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:39","pubTimestamp":1715942340,"startTime":"0","endTime":"0","summary":"甘李药业公告，尹磊先生因个人原因申请辞去公司董事职务，辞职后仍将在公司担任其他职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171840278b124535&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171840278b124535&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436969123","title":"直击股东大会｜甘李药业甘忠如：目标是代谢病领域的“全球老大”","url":"https://stock-news.laohu8.com/highlight/detail?id=2436969123","media":"银柿财经","top":-1,"share":"https://www.laohu8.com/m/news/2436969123?lang=zh_cn&edition=full","pubTime":"2024-05-17 14:55","pubTimestamp":1715928958,"startTime":"0","endTime":"0","summary":"过去的4月，甘李药业可以说是“利好频传”。4月23日，全国胰岛素集采续约开标，甘李药业旗下6个产品及相关品规在本轮采购中均中选，且此次拟中选报价较上一次集采均有不同程度的小幅度上涨。然而甘忠如指出，甘李药业的终极目的是在胰岛素、糖尿病和代谢病领域做中国老大甚至全球老大，要实现这个目标，就需要有创新药、新产品。甘李药业北京总部厂区的迎宾堂外，股东大会结束后投资者正聚集在一处甘李药业北京总部厂区大门外","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171456188b118d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171456188b118d03&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436958341","title":"北向资金5月16日净卖出甘李药业16.72万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2436958341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436958341?lang=zh_cn&edition=full","pubTime":"2024-05-17 09:30","pubTimestamp":1715909428,"startTime":"0","endTime":"0","summary":"5月16日，北向资金减持甘李药业16.72万股连续3日减持。截止当日收盘，沪股通共持有甘李药业771.08万股，占流通股1.44%。沪股通减持金额前五个股分别为伊利股份、国电南瑞、中国石化、恒瑞医药、中国联通。甘李药业近5个交易日下跌3.89%，沪股通累计增持81.12万股；近20个交易日上涨8.88%，沪股通累计增持248.45万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170933548b10bf2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170933548b10bf2e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435616158","title":"生物制品行业盘中拉升，甘李药业涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435616158","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435616158?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:47","pubTimestamp":1715824034,"startTime":"0","endTime":"0","summary":"05月16日，生物制品行业盘中拉升，截至09点47分，生物制品行业整体指数上涨0.52%，报6712.070点。从个股上来看，该行业的成分股中，甘李药业涨1.81%，博雅生物、科兴制药、百济神州-U涨幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为-4103.71万，其中天坛生物受到资金热捧，主力净流入544.66万；拉长时间线来看，该板块近20日主力资金净流入-19.24亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405160947147a5a2265&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405160947147a5a2265&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435828664","title":"甘李药业胰高血糖素样肽-1受体激动剂GZR18 Ib/IIa期临床研究达成主要终点和所有关键次要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2435828664","media":"甘李药业","top":-1,"share":"https://www.laohu8.com/m/news/2435828664?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:46","pubTimestamp":1715769962,"startTime":"0","endTime":"0","summary":"关于甘李药业甘李药业股份有限公司作为中国第一家掌握产业化生产重组胰岛素类似物技术的高科技生物制药企业，具备完整胰岛素研发管线。在未来，甘李药业将实现在糖尿病诊断和治疗领域产品线全面覆盖，进一步提升公司在糖尿病治疗领域的市场竞争力。公司还将积极投入到化学药、真核及原核蛋白质工程、肿瘤和心血管及代谢病等研究领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405160354468b0c36ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405160354468b0c36ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435568000","title":"甘李药业：5月15日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2435568000","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2435568000?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:13","pubTimestamp":1715767981,"startTime":"0","endTime":"0","summary":"甘李药业（SH 603087，收盘价：47.95元）5月15日晚间发布公告称，公司第四届第十九次董事会会议于2024年5月15日在公司五层会议室以现场结合通讯方式召开。审议了《关于调整公司2024年限制性股票激励计划激励对象名单和授予数量的议案》等。截至发稿，甘李药业市值为285亿元。文章来源：每日经济新闻原标题：甘李药业：5月15日召开董事会会议","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151819158b0af9bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151819158b0af9bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435168073","title":"甘李药业最新公告：高管孙程拟30万元-50万元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2435168073","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435168073?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:11","pubTimestamp":1715767877,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司近日收到公司副总经理孙程拟增持公司股份计划的通知。孙程计划自本公告披露之日起6个月内，通过集中竞价交易方式增持公司股份，合计增持金额为人民币30万元（含）-50万元（含）。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031049.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435680895","title":"甘李药业：高级管理人员拟以30-50万元增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2435680895","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2435680895?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:04","pubTimestamp":1715767440,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司副总经理孙程拟以30-50万元增持公司股份。本次增持不设价格区间，将根据公司股票价格波动情况，逐步实施增持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151804007a5a065f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151804007a5a065f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435851680","title":"甘李药业(603087.SH)：向激励对象授予704万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2435851680","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2435851680?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:00","pubTimestamp":1715767257,"startTime":"0","endTime":"0","summary":"格隆汇5月15日丨甘李药业(603087.SH)公布，公司确定以2024年5月15日为授予日，以人民币19.79元/股的授予价格向符合授予条件的87名激励对象授予704万股限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151801008b0aeaf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151801008b0aeaf8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435368082","title":"甘李药业(603087.SH)：副总经理孙程拟增持30万元-50万元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2435368082","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2435368082?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:00","pubTimestamp":1715767206,"startTime":"0","endTime":"0","summary":"格隆汇5月15日丨甘李药业(603087.SH)公布，公司于近日收到公司副总经理孙程先生拟增持公司股份计划的通知，计划自本公告披露之日起6个月内，通过集中竞价交易方式增持公司股份，合计增持金额为人民币30万元(含)-50万元(含)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151800188b0aea3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151800188b0aea3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435718723","title":"对话北京创新药新政下的药企 ｜ 三代胰岛素国内采购需求量升至24% 甘李药业提速国际化","url":"https://stock-news.laohu8.com/highlight/detail?id=2435718723","media":"北京商报","top":-1,"share":"https://www.laohu8.com/m/news/2435718723?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:21","pubTimestamp":1715610092,"startTime":"0","endTime":"0","summary":"甘李药业是我国胰岛素龙头企业之一。截至2022年底，甘李药业新准入了近1.6万家的医疗机构，国内制剂产品销量同比增长29.77%。据透露，在今年4月的国家胰岛素专项接续采购中，该公司三代胰岛素类似物采购需求量从首次的占比14%上升至24%。近年来，甘李药业积极开拓全球海外市场。文章来源：北京商报文章作者：姚倩对话北京创新药新政下的药企 ｜ 三代胰岛素国内采购需求量升至24% 甘李药业提速国际化","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513222915876297c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513222915876297c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435702344","title":"甘李药业：公司持续加强对药物研究与开发团队的研发投入和能力建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2435702344","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435702344?lang=zh_cn&edition=full","pubTime":"2024-05-13 17:02","pubTimestamp":1715590930,"startTime":"0","endTime":"0","summary":"甘李药业董秘：尊敬的投资者您好，公司磷酸西格列汀片预计将在2024年下半年原研产品相关专利到期后进行上市销售。请董秘介绍一下调研及药物相关情况。一直关注公司糖尿病以外管线的药物研发。在不断深耕糖尿病以及相关适应症的新药研发领域的同时，其他适应症的药物研发也在进行中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131704158b00ca1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131704158b00ca1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435391692","title":"甘李药业获西南证券持有评级，业绩符合预期，接续集采中标未来盈利可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2435391692","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435391692?lang=zh_cn&edition=full","pubTime":"2024-05-13 10:33","pubTimestamp":1715567622,"startTime":"0","endTime":"0","summary":"5月13日， 甘李药业 获 西南证券 持有评级，近一个月甘李药业获得2份研报关注。研报预计2024-2026年EPS分别为1.22元、2.04元、2.38元，胰岛素接续集采拟中选结果2024年4月发布，公司中标价有所上升。按照集采报量计算加权平均涨价幅度约在20%-30%。预计新集采价格有望于24年6月以后陆续执行，随着接续集采签约工作的逐步推进，公司产品销量有望逐季度恢复。研报认为，公司看好公司胰岛素国内集采后放量+出海欧美的增长潜力。风险提示：产品价格下降风险、在研管线进展或不及市场预期、市场竞争风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051310393487604e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051310393487604e92&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434588431","title":"甘李药业05月10日遭主力抛售7982万元 环比增加179.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434588431","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434588431?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:19","pubTimestamp":1715325579,"startTime":"0","endTime":"0","summary":"05月10日, 甘李药业股价跌3.79%，报收48.50元，成交金额6.66亿元，换手率2.55%，振幅4.09%，量比1.02。甘李药业今日主力资金净流出7982万元，连续4日净流出，上一交易日主力净流出2856万元，今日环比增加179.48%。该股近5个交易日下跌3.08%，主力资金累计净流出2.03亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入4904万元，其中净流入天数为10日。净流出前三个股分别为智飞生物、甘李药业、博雅生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510154205874fb444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510154205874fb444&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434078841","title":"甘李药业（603087）118.92万股限售股将于5月10日解禁上市，占总股本0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434078841","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434078841?lang=zh_cn&edition=full","pubTime":"2024-05-10 08:03","pubTimestamp":1715299398,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，甘李药业于5月10日将有118.92万股限售股份解禁上市，为公司股权激励限售股份，占公司总股本0.2%。最近一年内，该股累计解禁2.34亿股，占总股本的39.42%。本次解禁后，公司还有6189.77万股限售股份，占总股本10.42%。甘李药业主营业务：公司主要从事重组胰岛素类似物原料药及注射剂的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000011502.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434086239","title":"甘李药业获融资买入0.65亿元，近三日累计买入2.43亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434086239","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434086239?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:25","pubTimestamp":1715214334,"startTime":"0","endTime":"0","summary":"5月8日，沪深两融数据显示，甘李药业获融资买入额0.65亿元，居两市第121位，当日融资偿还额0.69亿元，净卖出368.24万元。最近三个交易日，6日-8日，甘李药业分别获融资买入1.13亿元、0.65亿元、0.65亿元。融券方面，当日融券卖出1.36万股，净买入4.37万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090827588aea621d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090827588aea621d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-29","address":"北京市通州区漷县镇南凤西一路8号","stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":0.1338},{"period":"3month","weight":0.2126},{"period":"6month","weight":0.0091},{"period":"1year","weight":0.3476},{"period":"ytd","weight":-0.076}],"companyName":"甘李药业股份有限公司","boardCode":"AI0027","perCapita":"6353股","boardName":"医药制造业","registeredCapital":"59416万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　甘李药业股份有限公司主要从事重组胰岛素类似物原料药及注射剂的研发、生产和销售。公司主要产品包括重组甘精胰岛素注射液、重组赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液五个胰岛素类似物品种。公司为唯一掌握产业化生产重组胰岛素类似物技术的中国企业，使得我国成为世界上少数能进行重组胰岛素类似物产业化生产的国家之一。","serverTime":1716102564625,"listedPrice":63.32,"stockholders":"83780人(较上一季度减少3.14%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"甘李药业,603087,甘李药业股票,甘李药业股票老虎,甘李药业股票老虎国际,甘李药业行情,甘李药业股票行情,甘李药业股价,甘李药业股市,甘李药业股票价格,甘李药业股票交易,甘李药业股票购买,甘李药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}